As IFNα has been approved for treating several neoplasms, we compared the anti-tumor effects of IFNα and IFNα-MSCs, and found that IFNα-MSCs exhibited a much more powerful suppression on tumor growth than that of intra-tumoral injection of IFNα (Fig. 2I). Here, IFNA1 is linked to neoplasm.